Breakthrough: Russian cancer vaccine success
The first melanoma patient treated with Neooncovac is feeling well and has developed the required immune response.
The first melanoma patient treated with Neooncovac is feeling well and has developed the required immune response.
This new treatment trains the immune system to detect and destroy cancer cells before they can grow or spread, offering a potentially life-saving alternative to traditional therapies like chemotherapy.
This includes real-world use studies confirming safety and effectiveness, joint ventures (e.g., with Russia), and availability for medical tourism in Cuba for lung and other cancers.
Recent Comments